LivaNova gains after positive predictive outcome of sleep apnea study [Seeking Alpha]
LivaNova PLC - Ordinary Shares (LIVN)
Last livanova plc - ordinary shares earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
livanova.com
Company Research
Source: Seeking Alpha
"There is a greater than 97.5% probability that the OSPREY trial will successfully meet its primary endpoint without further patient enrollment," the company said in a statement LivaNova ( LIVN ) notified the U.S. Food and Drug Administration (FDA) and its partner trial sites of this significant milestone. OSPREY is a prospective, multi-center trial to evaluate the safety and effectiveness of LivaNova's aura6000 Hypoglossal Nerve Stimulator System versus a no stimulation control in subjects with moderate to severe obstructive sleep apnea who have failed or are unwilling to use positive airway pressure treatment. The company will submit OSPREY's final clinical module to the FDA once the full cohort completes the seven-month follow-up visit and the results are compiled. Recommended For You More Trending News Recommended For You More Trending News About LIVN Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
LIVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LIVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LIVN alerts
High impacting LivaNova PLC - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
LIVN
News
- LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.MarketBeat
- LivaNova (LIVN) Q1 Earnings and Revenues Top Estimates [Yahoo! Finance]Yahoo! Finance
- LivaNova beats top-line and bottom-line estimates; raises FY24 outlook [Seeking Alpha]Seeking Alpha
- LivaNova Reports First-Quarter 2024 Results [Yahoo! Finance]Yahoo! Finance
- LivaNova Reports First-Quarter 2024 ResultsBusiness Wire
LIVN
Earnings
- 5/1/24 - Beat
LIVN
Sec Filings
- 5/1/24 - Form 8-K
- 4/26/24 - Form ARS
- 4/26/24 - Form DEF
- LIVN's page on the SEC website